{"product_id":"uscap-thorax-revisited-2026","title":"USCAP Thorax Revisited 2026","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"bbb44b8\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003ch1\u003eUSCAP Thorax Revisited 2026\u003c\/h1\u003e\n\u003cstrong\u003e+ Include: 10 videos + 20 pdfs, size:  GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: pathologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eOriginal release date: January 12, 2026\u003cbr\u003e\u003cbr\u003eAccurate diagnosis of pleural disease is crucial to patient care. Pathologists are also increasingly asked to order and interpret molecular testing for lung carcinomas and other pulmonary tumors. Led by expert pathologists, this course will review common diagnostic pitfalls in thoracic pathology, cytology, and immunohistochemistry, along with new cases of mediastinal tumors, pleural tumors, and non-neoplastic lung disease. As molecular testing becomes more mainstream, interpreting these tests for lung carcinomas and other pulmonary tumors is of vital importance. Faculty will discuss issues related to molecular testing with a focus on what to order, when to order, and how to interpret the results. This course will feature lectures and interactive case-based discussions.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003cbr\u003ePracticing academic and community pathologists, and pathologists-in-training\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003cbr\u003eUpon completion of this educational activity, learners will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eUnderstand when molecular testing is needed for thoracic tumors, what tests are appropriate, and how to interpret the results.\u003c\/li\u003e\n\u003cli\u003eBecome familiar with morphologic features of various prevascular mediastinal lesions for establishing a reasonable differential diagnosis. Based on that differential diagnosis the participants will learn to apply reasonable small panels of ancillary tests, including immunostains and potentially cytogenetics (especially chromosome 12p alterations for germ cell tumors).\u003c\/li\u003e\n\u003cli\u003eBecome familiar with morphologic features of various non neoplastic lung diseases. Cases selected will span the spectrum of cellular and fibrotic interstitial pneumonias, smoking related disease, cystic lung disease, benign lymphoid lesions (and some neoplastic mimics), vascular disease, drug reactions, the lung in systemic disease, and various granulomatous diseases. These cases form the bulk of cases sent to our large consultation practice indicating that pathologists struggle with how to report their findings and to communicate the clinical significance of what they are seeing.\u003c\/li\u003e\n\u003cli\u003eUnderstand the various types of pleural lesions encountered in everyday practice, their morphologic differential and mimics, and what adjunctive tests are or are not useful in working up such cases.\u003c\/li\u003e\n\u003cli\u003eGain familiarity with the basics of thoracic cytology (lavage, EBUS, effusion) specimens, understand issues related to specimen preparation, and how and when to apply immunostains or FISH.\u003c\/li\u003e\n\u003cli\u003eLearn efficient use of immunostains for thoracic lesions and learn to recognize problems and misleading results with such stains.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"product-program__lesson\" data-v-9ad12abf=\"\"\u003e\n\u003cul\u003e\n\u003cli data-end=\"130\" data-start=\"63\"\u003e\n\u003cp data-end=\"130\" data-start=\"66\"\u003e\u003cstrong data-end=\"99\" data-start=\"66\"\u003eBasics of Molecular Pathology\u003c\/strong\u003e – Yin (Rex) P. Hung, MD, PhD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"171\" data-start=\"131\"\u003e\n\u003cp data-end=\"171\" data-start=\"134\"\u003e\u003cstrong data-end=\"149\" data-start=\"134\"\u003eMediastinum\u003c\/strong\u003e – Anja C. Roden, MD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"213\" data-start=\"172\"\u003e\n\u003cp data-end=\"213\" data-start=\"175\"\u003e\u003cstrong data-end=\"191\" data-start=\"175\"\u003eIHC Pitfalls\u003c\/strong\u003e – Anja C. Roden, MD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"253\" data-start=\"214\"\u003e\n\u003cp data-end=\"253\" data-start=\"217\"\u003e\u003cstrong data-end=\"227\" data-start=\"217\"\u003ePleura\u003c\/strong\u003e – Andrew Churg, MD, PhD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"295\" data-start=\"254\"\u003e\n\u003cp data-end=\"295\" data-start=\"257\"\u003e\u003cstrong data-end=\"269\" data-start=\"257\"\u003eCytology\u003c\/strong\u003e – Andrew Churg, MD, PhD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"377\" data-start=\"296\"\u003e\n\u003cp data-end=\"377\" data-start=\"299\"\u003e\u003cstrong data-end=\"355\" data-start=\"299\"\u003eGross–Microscopic Correlations in Thoracic Pathology\u003c\/strong\u003e – Anja C. Roden, MD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"433\" data-start=\"378\"\u003e\n\u003cp data-end=\"433\" data-start=\"381\"\u003e\u003cstrong data-end=\"407\" data-start=\"381\"\u003eNon-Neoplastic: Part 1\u003c\/strong\u003e – Henry D. Tazelaar, MD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"489\" data-start=\"434\"\u003e\n\u003cp data-end=\"489\" data-start=\"437\"\u003e\u003cstrong data-end=\"463\" data-start=\"437\"\u003eNon-Neoplastic: Part 2\u003c\/strong\u003e – Henry D. Tazelaar, MD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"553\" data-start=\"490\"\u003e\n\u003cp data-end=\"553\" data-start=\"493\"\u003e\u003cstrong data-end=\"522\" data-start=\"493\"\u003eMolecular Testing: Part 1\u003c\/strong\u003e – Yin (Rex) P. Hung, MD, PhD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"618\" data-start=\"554\"\u003e\n\u003cp data-end=\"618\" data-start=\"558\"\u003e\u003cstrong data-end=\"587\" data-start=\"558\"\u003eMolecular Testing: Part 2\u003c\/strong\u003e – Yin (Rex) P. Hung, MD, PhD\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954535993442,"sku":"MED-AMB05557","price":120.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/USCAP-Thorax-Revisited-2026.jpg?v=1779379192","url":"https:\/\/meducourse.com\/products\/uscap-thorax-revisited-2026","provider":"Meducourse","version":"1.0","type":"link"}